The advertisement promotes Stivarga (regorafenib) tablets, highlighting a $0 co-pay offer for eligible patients and financial support options, while also providing important safety warnings regarding hepatotoxicity.
Creative Information
| CID: | 19958177-874c-4682-9f3f-a7f4004c574f |
| CRID: | 82_1075-651751 |
| Domain: | stivarga-us.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $22.81 |
| Timestamp: | 11/4/2025, 4:06:25 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 4:48:36 PM | 5.69s | |
| adomain_analysis | success | 11/4/2025, 6:46:19 PM | 3.16s | |
| adomain_capture | success | 11/4/2025, 6:46:16 PM | 0.17s | |
| ad_render | success | 11/4/2025, 4:48:30 PM | 24.80s | |
| brand_mapping | success | 11/4/2025, 4:06:26 PM | 1.22s | |
Analysis Results
Ad Format: banner
Brands: Stivarga
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1086.79 KB | ||||||||||||||||||||||
| Render Time: | 9.34 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1086.84 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


